Key compounds may be involved in inhibiting STAT3 expression, thereby blocking the expression of downstream inflammatory factors involved in RA pathogenesis, and thereby blocking the immune response induced by the JAK-STAT signaling pathway (S3A Fig). Here, STAT3 is linked to rheumatoid arthritis.